NKTR
Nektar Therapeutics
Latest News for NKTR
In a report released today, Samantha Semenkow from Citi reiterated a Buy rating on Nektar Therapeutics, with a price target of $123.00. Semenkow co......
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Nektar Therapeutics (NKTR), Solventum Corporation (S......
Nektar Therapeutics ($NKTR) told investors its REZOLVE-AA trial followed stated eligibility criteria and protocol standards. Executives repeatedly ......
Important Notice Regarding Alleged Clinical Trial Enrollment Misrepresentations NEW YORK, March 26, 2026 — Levi & Korsinsky, LLP notifies investors......
Nektar Therapeutics (NKTR) promoted rezpegaldesleukin as a promising drug candidate and described the REZOLVE-AA study’s enrollment criteria and tr......
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Nektar Therapeutics (NKTR – Research Report), OnKure......
Nektar Therapeutics (($NKTR)) has held its Q4 earnings call. Read on for the main highlights of the call. Nektar Therapeutics’ latest earnings call......
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Climb Bio (CLYM – Research Report) and Nektar Therap......
News data is sourced from MarketXLS API and updated regularly.
Showing 8 of 8 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NKTR | $75.10 | -1.5% | 565.89K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |